Evidence map›Paper›PMID 36127338›Full record

ArticleCell death & disease2022

Retraction Note: Annonacin promotes selective cancer cell death via NKA-dependent and SERCA-dependent pathways.

Andreas Yiallouris, Ioannis Patrikios, Elizabeth O Johnson, Evangelia Sereti, Konstantinos Dimas, Cristian De Ford, Natalia U Fedosova, Wolfgang F Graier, Kleitos Sokratous, Kyriakos Kyriakou and 1 more

RetractedOpen access · goldAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 5 countries.

Andreas YiallourisSchool of Medicine, European University Cyprus, Nicosia, Cyprus.
Ioannis PatrikiosSchool of Medicine, European University Cyprus, Nicosia, Cyprus. i.patrikios@euc.ac.cy.
Elizabeth O JohnsonSchool of Medicine, European University Cyprus, Nicosia, Cyprus.
Evangelia SeretiDepartment of Pharmacology, School of Health Sciences, University of Thessaly, Volos, Greece.
Konstantinos DimasDepartment of Pharmacology, School of Health Sciences, University of Thessaly, Volos, Greece.
Cristian De FordDepartment of Pharmaceutical Biology and Biotechnology, Spemann Graduate School of Biology and Medicine (SGBM), Albert Ludwigs University Freiburg, Freiburg, Germany.
Natalia U FedosovaDepartment of Biomedicine-Physiology and Biophysics, Aarhus University, Aarhus, Denmark.
Wolfgang F GraierGottfried Schatz Research Center, Molecular Biology & Biochemistry, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-1871-3298
Kleitos SokratousDepartment of EM/Molecular Pathology, Institute of Neurology and Genetics, Nicosia, Cyprus.
Kyriakos KyriakouDepartment of EM/Molecular Pathology, Institute of Neurology and Genetics, Nicosia, Cyprus.
Anastasis StephanouSchool of Medicine, European University Cyprus, Nicosia, Cyprus. a.stephanou@euc.ac.cy.
Cyprus Institute of Neurology and Genetics · CYEuropean University Cyprus · CYNational and Kapodistrian University of Athens · GRUniversity of Thessaly · GRAarhus University · DKMedical University of Graz · ATUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36127338
PMCPMC9489760
OpenAlexW4296392061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.